Biosimulation Trends: Market Research Report
Biosimulation is the mathematical simulation of complex, large biological processes on a computer. Biosimulation is being adopted at a faster pace, to extract and interpret vital data from experiments during drug discovery and development.
The report analyzes and presents an overview of Biosimulation market worldwide. The report provides global market estimates and projections for Biosimulation in US dollars for the years 2012 through 2017. Supported with 1 market data table, the report highlights the ever increasing permanence of Biosimulation. The report also provides a review of Biosimulation Models, and Biosimulation software. In addition, 36 companies operating in the Dye Sensitized Cells arena worldwide including Accelrys Inc., Entelos Inc., Rhenovia Pharma SAS and others are profiled.
The report analyzes and presents an overview of Biosimulation market worldwide. The report provides global market estimates and projections for Biosimulation in US dollars for the years 2012 through 2017. Supported with 1 market data table, the report highlights the ever increasing permanence of Biosimulation. The report also provides a review of Biosimulation Models, and Biosimulation software. In addition, 36 companies operating in the Dye Sensitized Cells arena worldwide including Accelrys Inc., Entelos Inc., Rhenovia Pharma SAS and others are profiled.
1. BIOSIMULATION – A MARKET OVERVIEW
A Prelude
Biosimulation - Revolutionizing Drug Discovery
Biosimulation - Models
Biosimulation Software
2. RECENT INDUSTRY ACTIVITY
Accelrys Introduces Discovery Studio 3. 5
Rhenovia Pharma Introduces Drug Development Programs for Orphan, Neglected and Rare Neurodegenerative Diseases
Rhenovia Pharma Sets Up International Subsidiary in the US
Rhenovia Pharma Inks an Agreement with Portmann
Entelos and RegeneMed Introduce iToxFX Service
3. MARKET PARTICIPANTS
Accelrys, Inc. (USA)
Advanced Chemistry Development, Inc. (Canada)
Anoixis Corporation (USA)
Aptiv Solutions (USA)
Archimedes, Inc. (USA)
Certara LP (USA)
Chemical Computing Group, Inc. (Canada)
Cognigen Corporation (USA)
Compugen Ltd. (Israel)
Entelos, Inc. (USA)
Genedata AG (Switzerland)
GNS Healthcare (USA)
Immunetrics, Inc. (USA)
In Silico Biosciences, Inc. (USA)
InhibOx Ltd. (UK)
INOSIM Software GmbH (Germany)
Insilico Biotechnology AG (Germany)
Kinetigen, Inc. (USA)
LeadInvent (India)
Leadscope, Inc. (USA)
Molecular Knowledge Systems, Inc. (USA)
Nimbus Discovery LLC (USA)
Novo Nordisk A/S (Denmark)
Open Eye Scientific Software, Inc. (USA)
Optimata Ltd. (Israel)
PhinC Development (France)
Physiomics PLC (UK)
Rhenovia Pharma SAS (France)
Rosa & Company LLC (USA)
Schrodinger LLC (USA)
Simcyp Ltd. (UK)
Simulations Plus, Inc. (USA)
Synergix Ltd. (Israel)
Tessella Ltd. (UK)
TheraSim (USA)
VirtuCel, Inc. (USA)
4. APPENDIX
A Prelude
Table 1. Global Biosimulation Market (2012-2017) in US$ Million
Biosimulation - Revolutionizing Drug Discovery
Biosimulation - Models
Biosimulation Software
2. RECENT INDUSTRY ACTIVITY
Accelrys Introduces Discovery Studio 3. 5
Rhenovia Pharma Introduces Drug Development Programs for Orphan, Neglected and Rare Neurodegenerative Diseases
Rhenovia Pharma Sets Up International Subsidiary in the US
Rhenovia Pharma Inks an Agreement with Portmann
Entelos and RegeneMed Introduce iToxFX Service
3. MARKET PARTICIPANTS
Accelrys, Inc. (USA)
Advanced Chemistry Development, Inc. (Canada)
Anoixis Corporation (USA)
Aptiv Solutions (USA)
Archimedes, Inc. (USA)
Certara LP (USA)
Chemical Computing Group, Inc. (Canada)
Cognigen Corporation (USA)
Compugen Ltd. (Israel)
Entelos, Inc. (USA)
Genedata AG (Switzerland)
GNS Healthcare (USA)
Immunetrics, Inc. (USA)
In Silico Biosciences, Inc. (USA)
InhibOx Ltd. (UK)
INOSIM Software GmbH (Germany)
Insilico Biotechnology AG (Germany)
Kinetigen, Inc. (USA)
LeadInvent (India)
Leadscope, Inc. (USA)
Molecular Knowledge Systems, Inc. (USA)
Nimbus Discovery LLC (USA)
Novo Nordisk A/S (Denmark)
Open Eye Scientific Software, Inc. (USA)
Optimata Ltd. (Israel)
PhinC Development (France)
Physiomics PLC (UK)
Rhenovia Pharma SAS (France)
Rosa & Company LLC (USA)
Schrodinger LLC (USA)
Simcyp Ltd. (UK)
Simulations Plus, Inc. (USA)
Synergix Ltd. (Israel)
Tessella Ltd. (UK)
TheraSim (USA)
VirtuCel, Inc. (USA)
4. APPENDIX
